LL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control

dc.creatorVignoni, Mariana
dc.creatorde Alwis Weerasekera, Hasitha
dc.creatorSimpson, Madeline J.
dc.creatorPhopase, Jaywant
dc.creatorMah, Thien Fah
dc.creatorGriffith, May
dc.creatorAlarcon, Emilio I.
dc.creatorScaiano, Juan C.
dc.date.accessioned2016-04-08T17:28:13Z
dc.date.available2016-04-08T17:28:13Z
dc.date.created2016-04-08T17:28:13Z
dc.date.issued2014-04
dc.identifierVignoni, Mariana; de Alwis Weerasekera, Hasitha; Simpson, Madeline J.; Phopase, Jaywant; Mah, Thien Fah ; et al.; LL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control; Royal Society of Chemistry; Nanoscale; 6; 11; 4-2014; 5725-5728
dc.identifier2040-3372
dc.identifierhttp://hdl.handle.net/11336/5086
dc.description.abstractCapping silver nanoparticles with LL37 peptide eradicates the antiproliferative effect of silver on primary skin cells, but retains the bactericidal properties of silver nanoparticles with activities comparable to silver nitrate or silver sulfadiazine. In addition, LL37 capped silver nanoparticles have anti-biofilm formation activity.
dc.languageeng
dc.publisherRoyal Society of Chemistry
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://pubs.rsc.org/en/content/articlelanding/2014/nr/c4nr01284d#!divAbstract
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1039/c4nr01284d
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNanoparticles
dc.subjectSkin Infection
dc.subjectLl37 Peptide
dc.titleLL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución